Adherence to HIV/AIDS Treatment: Research

Alcohol Use and Antiretroviral Adherence: Review and Meta-Analysis (September 22, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Methamphetamine Use, Sexual Activity, Patient-Provider Communication, and Medication Adherence Among HIV-Infected Patients in Care, San Francisco, 2004-2006 (September 1, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Alcohol and HIV: Not a Good Mix for Treatment Adherence (August 14, 2009)
A U.S. analysis of 40 previous studies on alcohol and HIV found that HIVers who drank alcohol were half as likely to remember their HIV meds compared to HIVers who never drank at all.
From aidsmap.com
The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time (March 31, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Higher Mortality Seen Among HIV-Positive People Who Miss Clinic Appointments, Study Says (February 13, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Effect of Incentives for Medication Adherence on Health Care Use and Costs in Methadone Patients With HIV (February 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
High Adherence May Become Less Essential the Longer a Patient Maintains Viral Suppression on HAART, Findings Suggest (February 11, 2009)
Maximum adherence should always remain a goal when taking HAART. However, patients with sustained viral suppression on HAART are highly likely to maintain that viral suppression even in the face of adherence rates much lower than 95 percent, reports David Bangsberg, M.D., M.P.H.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
HIV Patients Who Miss Appointments Have Increased Risk of Death (January 12, 2009)
From aidsmap.com
Adherence of 80-95% Not Good Enough for Long-Term Treatment Success in British Columbia HIV Patients (December 12, 2008)
If a person is taking an "older" HIV treatment regimen and misses more than one dose a week, his or her HIV meds will probably lose their effectiveness within the next few years, Canadian researchers find.
From aidsmap.com
Modern HIV Treatment Can Work Well With Adherence Below 95% (November 7, 2008)
A new Spanish study suggests that even if you miss one out of every five doses, the odds are still relatively low that your HIV meds will stop controlling HIV over the next year, provided you're on a powerful regimen using the newer meds.
From aidsmap.com
Researchers Develop Breath-Monitoring Device to Monitor Treatment Adherence Among HIV-Positive People (April 23, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Among Patients on Boosted-PI Regimens, Dose Staggering and Selective Non-Adherence to Ritonavir Is Relatively Common (February 6, 2008)
From The Body PRO
HIV-Positive People With Depression More Likely to Follow Treatment Regimens When Taking SSRIs, Study Finds (January 8, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Effects of Adherence Support Programmes May Be Short Lived (January 2, 2008)
From aidsmap.com
Consequences of Non-Adherence Worse in African-Americans Than White People (December 16, 2007)
From aidsmap.com
Adherence to HIV Treatment Linked to Health Literacy, Study Finds (November 19, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Once-Daily Nevirapine Doesn't Improve Adherence, May Increase Risk of Treatment Break and Resistance (October 26, 2007)
From aidsmap.com
Pillboxes Should Be Standard Issue for HIV Patients, Study Concludes (September 10, 2007)
From aidsmap.com
Lower Adherence May Precede Viral Load "Blips" (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Higher Degree of Medication "Forgiveness" in Use of Boosted Protease Inhibitors (August 15, 2006)
In The XVI International AIDS Conference
HIV JournalView: Adherence, Viral Fitness and NNRTI and PI Resistance (February/March 2006)
Bangsberg et al find that NNRTIs are more likely to suppress HIV than a single PI, but are also more vulnerable to resistance at low adherence levels.
From The Body PRO
Industry-Sponsored Study Examines Factors Influencing Adherence (Winter 2005/2006)
The demands of life and work are the biggest obstacles to perfect adherence, HIVers say.
To read PDF, click here
In Body Positive, from Body Positive
Literature Review: Antidepressant Treatment Improves Adherence to Antiretrovirals (January 2006)
In Infectious Diseases in Corrections Report, from Brown Medical School